Gilead Sciences (France)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (France), France, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
236
Total Open
Publications
121
Total
Citations
7.2K
Open Access
Percentage
51%
Total
Publications
236
Total Open
Publications
121
Total
Citations
7.2K
Breakdown
Publisher Open
33%
Both
14%
Other Platform Open
4%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
34
Hybrid 25%
27
No Guarantees 44%
48
Other Platform Open
Domain 81%
34
Institution 29%
12
Other Internet 21%
9
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 34 |
DOI | Other Internet | 7 |
Unknown Repository | Other Internet | 2 |
University of Michigan - Deep Blue | Institution | 2 |
University of Genoa - CINECA IRIS Institutial Research Information System | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
Belarusian State Pedagogical University - Belarusian State Pedagogical University repository | Institution | 2 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 1 |
Utrecht University - Utrecht University Repository | Institution | 1 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |